Apotheca Biosciences, Inc.
company.status.inactiveCIK 1632053fmd_00X18BS3BAAKKNA5K43EEH0CR4Mining · Metal MiningTemplate: Standard
Coverage: Feb 01, 2014 to Apr 30, 2019, 18 periods
Latest annual · FY2018
Millions- Operating income
- (0)
- Net income
- (0)
Latest quarter · Q1 FY2020
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (0)
Apotheca Biosciences, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2018 | FY2017 | Change | Source |
|---|---|---|---|---|
| Operating income | -$188,149 | -$14,771 | 10-K 2018-05-18 · proof | |
| Net income | -$195,780 | -$17,786 | 10-K 2018-05-18 · proof | |
| Cash from operating activities | -$34,089 | -$3,341 | 10-K 2018-05-18 · proof | |
| Total assets | $0 | $489 | -100% | 10-K 2018-05-18 · proof |
| Total liabilities | $222,249 | $33,135 | +570.7% | 10-K 2018-05-18 · proof |
| Cash and cash equivalents | $0 | $489 | -100% | 10-Q 2018-10-02 · proof |
- What was Apotheca Biosciences, Inc.'s operating income in fiscal 2018?
- Apotheca Biosciences, Inc. reported operating income of -$188,149 for fiscal 2018 (the year ended Jan 31, 2018), against -$14,771 the year before. Source: the 10-K filed with the SEC on May 18, 2018. SEC
- What was Apotheca Biosciences, Inc.'s net income in fiscal 2018?
- Apotheca Biosciences, Inc. reported net income of -$195,780 for fiscal 2018 (the year ended Jan 31, 2018), against -$17,786 the year before. Source: the 10-K filed with the SEC on May 18, 2018. SEC
- What was Apotheca Biosciences, Inc.'s cash from operating activities in fiscal 2018?
- Apotheca Biosciences, Inc. reported cash from operating activities of -$34,089 for fiscal 2018 (the year ended Jan 31, 2018), against -$3,341 the year before. Source: the 10-K filed with the SEC on May 18, 2018. SEC
- What are Apotheca Biosciences, Inc.'s total assets?
- As of Jan 31, 2018, Apotheca Biosciences, Inc. reported total assets of $0, against $489 a year earlier (-100%). Source: the 10-K filed with the SEC on May 18, 2018. SEC
- What are Apotheca Biosciences, Inc.'s total liabilities?
- As of Jan 31, 2018, Apotheca Biosciences, Inc. reported total liabilities of $222,249, against $33,135 a year earlier (+570.7%). Source: the 10-K filed with the SEC on May 18, 2018. SEC
- What are Apotheca Biosciences, Inc.'s cash and cash equivalents?
- As of Jan 31, 2018, Apotheca Biosciences, Inc. reported cash and cash equivalents of $0, against $489 a year earlier (-100%). Source: the 10-Q filed with the SEC on Oct 2, 2018. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1632053&period_type=annual&limit=5"Information only, not investment advice.